AI assistant
EBOS GROUP LIMITED — Director's Dealing 2019
Dec 1, 2019
64813_rns_2019-12-01_88cb205c-7701-4281-8406-f37971ad233d.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [98 x 27] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| To NZX Limited; and | ||
|---|---|---|
| Name of listed issuer: | EBOS GroupLimited | |
| Date this disclosure made: | 2-Dec-19 | |
| Date of last disclosure: | N/A | |
| Director or senior managergiving disclosure | ||
| Full name(s): | Stuart McLauchlan | |
| Name of listed issuer: | EBOS GroupLimited | |
| Name of related body corporate (if applicable): | N/A | |
| Position held in listed issuer: | Director | |
| Summary of acquisition or disposal of relevant interest (excluding specified derivatives) | ||
| Class of affected quoted financial products: | Ordinaryshares | |
| Nature of the affected relevant interest(s): | Acquisition of shares on-market | |
| For that relevant interest- | ||
| Number held in class before acquisition or disposal: | Nil | |
| Number held in class after acquisition or disposal: | 2,000 | |
| Current registered holder(s): | Not known | |
| Registered holder(s)once transfers are registered: | JBWere(NZ)Nominees Limited | |
| Summary of acquisition or disposal of specified derivatives relevant interest (if applicable) | ||
| Type of affected derivative: | ||
| Class of underlyingfinancialproducts: | ||
| Details of affected derivative- | ||
| The notional value of the derivative (if any) or the notional amount of underlying financial | ||
| products(if any): | ||
| A statement as to whether the derivative is cash settled orphysicallysettled: | ||
| Maturitydate of the derivative(if any): | ||
| Expirydate of the derivative(if any): | ||
| Theprice specified in the terms of the derivative(if any): | ||
| Any other details needed to understand how the amount of the consideration payable | ||
| under the derivative or the value of the derivative is affected by the value of the | ||
| underlying financial products: | ||
| _For that derivative,- _ | ||
| Parties to the derivative: | ||
| If the director or senior manager is not a party to the derivative, the nature of the relevant | ||
| interestinthe derivative: | ||
| Details of transactions giving rise to acquisition or disposal | ||
| Total numberoftransactions towhich noticerelates: | 1 | |
| Details of transactions requiring disclosure- | ||
| Date oftransaction: | 26-Nov-19 | |
| Nature of transaction: | Acquistion of shares on-market | |
| Name ofany otherparty orparties to the transaction(if known): | N/A | |
| The consideration, expressed in New Zealand dollars, paid or received for the acquisition | ||
| or disposal. If the consideration was not in cash and cannot be readily by converted into a | ||
| cash value,describe the consideration: | $46,000.00 |
| Numberof financialproducts towhichthe transaction related: | 2,000 ordinaryshares | 2,000 ordinaryshares | |
|---|---|---|---|
| If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details— |
|||
| Whether relevantinterestswere acquired ordisposed ofduring a closed period: | No | ||
| Whether prior written clearance was provided to allow the acquisition or disposal to proceed duringthe closedperiod: |
N/A | ||
| Date of theprior written clearance(if any): | N/A | ||
| Summary of other relevant interests after acquisition or disposal: | |||
| Class ofquotedfinancialproducts: | |||
| Nature of relevantinterest: | |||
| _For that relevant interest,- _ | |||
| Number heldinclass: | |||
| Currentregisteredholder(s): | |||
| For a derivative relevant interest,- | |||
| Type ofderivative: | |||
| Details of derivative,- | |||
| The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): |
|||
| A statement as to whether the derivative is cash settled or physically settled: | |||
| Maturity date of the derivative (if any): | |||
| Expiry date of the derivative (if any): | |||
| The price's specified terms (if any): | |||
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlyingfinancialproducts: |
|||
| For that derivative relevant interest,- | |||
| Parties to the derivative: | |||
| If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative: |
|||
| Certification | 2-Dec-19 Janelle Cain, General Counsel, EBOS Group Limited |
||
| I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. |
|||
| Signature of director or officer: | |||
| Date of signature: | |||
| or | |||
| Signature of person authorised to sign on behalf of director or officer: | |||
| Date of signature: | |||
| Name and title of authorised person: | |||
==> picture [98 x 27] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| To NZX Limited; and | ||
|---|---|---|
| Name of listed issuer: | EBOS GroupLimited | |
| Date this disclosure made: | 2-Dec-19 | |
| Date of last disclosure: | 18-Oct-19 |
Director or senior manager giving disclosure Full name(s): Name of listed issuer: Name of related body corporate (if applicable): Position held in listed issuer:
Elizabeth Coutts EBOS Group Limited Director
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products: Nature of the affected relevant interest(s): For that relevant interest- Number held in class before acquisition or disposal: Number held in class after acquisition or disposal: Current registered holder(s): Registered holder(s) once transfers are registered:
Ordinary Appointed as trustee of the EBOS Staff Share Plan Nil 71,592 Mark Brendon Waller & John Matthew Cullity as trustees of the EBOS Staff Share Plan Elizabeth Mary Coutts & John Matthew Cullity as trustees of the EBOS Staff Share Plan
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative: Class of underlying financial products: Details of affected derivative- The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): A statement as to whether the derivative is cash settled or physically settled: Maturity date of the derivative (if any): Expiry date of the derivative(if any): The price specified in the terms of the derivative (if any): Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: For that derivative,- Parties to the derivative: If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 1
Details of transactions requiring disclosure-
Date of transaction: Nature of transaction: Name of any other party or parties to the transaction (if known): The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value, describe the consideration: Number of financial products to which the transaction related: If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details— Whether relevant interests were acquired or disposed of during a closed period: Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period: Date of the prior written clearance (if any):
2-Dec-19 Appointed as trustee of the EBOS Staff Share Plan N/A Nil 71,592 ordinary shares No N/A N/A
Summary of other relevant interests after acquisition or disposal:
| The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): |
|||
|---|---|---|---|
| A statement as to whether the derivative is cash settled or physically settled: | |||
| Maturity date of the derivative (if any): | |||
| Expiry date of the derivative (if any): | |||
| The price's specified terms (if any): | |||
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlyingfinancialproducts: |
|||
| For that derivative relevant interest,- | |||
| Parties to the derivative: | |||
| If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative: |
Certification
| I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. |
||
|---|---|---|
| Signature of director or officer: | ||
| Date of signature: | ||
| or | ||
| Signature of person authorised to sign on behalf of director or officer: | ||
| Date of signature: | 2-Dec-19 | |
| Name and title of authorised person: | Janelle Cain, General Counsel EBOS Group Limited |
|
==> picture [98 x 27] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| To NZX Limited; and | ||
|---|---|---|
| Name of listed issuer: | EBOS GroupLimited | |
| Date this disclosure made: | 2-Dec-19 | |
| Date of last disclosure: | 9-Apr-19 | |
| Director or senior managergiving disclosure | ||
| Full name(s): | Mark Waller | |
| Name of listed issuer: | EBOS GroupLimited | |
| Name of related body corporate (if applicable): | N/A | |
| Position held in listed issuer: | Former director | |
| Summary of acquisition or disposal of relevant interest (excluding specified derivatives) | ||
| Class of affected quoted financial products: | Ordinaryshares | |
| Nature of the affected relevant interest(s): | Retirement as trustee of the EBOS | |
| Staff Share Plan | ||
| For that relevant interest- | ||
| Number held in class before acquisition or disposal: | 71,592 | |
| Number held in class after acquisition or disposal: | Nil | |
| Mark Brendon Waller & John | ||
| Current registered holder(s): | Matthew Cullity as trustees of the | |
| EBOS Staff Share Plan | ||
| Elizabeth Mary Coutts & John | ||
| Registered holder(s) once transfers are registered: | Matthew Cullity as trustees of the | |
| EBOS Staff Share Plan | ||
| Summary of acquisition or disposal of specified derivatives relevant interest (if applicable) | ||
| Type of affected derivative: | ||
| Class of underlyingfinancialproducts: | ||
| Details of affected derivative- | ||
| The notional value of the derivative (if any) or the notional amount of underlying financial | ||
| products(if any): | ||
| A statement as to whether the derivative is cash settled orphysicallysettled: | ||
| Maturitydate of the derivative(if any): | ||
| Expirydate of the derivative(if any): | ||
| Theprice specified in the terms of the derivative(if any): | ||
| Any other details needed to understand how the amount of the consideration payable | ||
| under the derivative or the value of the derivative is affected by the value of the | ||
| underlying financial products: | ||
| _For that derivative,- _ | ||
| Parties to the derivative: | ||
| If the director or senior manager is not a party to the derivative, the nature of the relevant | ||
| interestinthe derivative: |
==> picture [435 x 79] intentionally omitted <==
----- Start of picture text -----
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 1
Details of transactions requiring disclosure-
Date of transaction: 2-Dec-19
Retirement as trustee of the EBOS
Nature of transaction: Employee Share Plan
----- End of picture text -----
Name of any other party or parties to the transaction (if known): The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value, describe the consideration: Number of financial products to which the transaction related: If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details— Whether relevant interests were acquired or disposed of during a closed period: Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period: Date of the prior written clearance (if any):
N/A Nil 71,592 ordinary shares No N/A N/A Ordinary shares Mark Brendon Waller & Angela Laura Waller 506,692 ordinary shares Mark Brendon Waller & Angela Laura Waller
Summary of other relevant interests after acquisition or disposal:
| Summary of other relevant interests after acquisition or disposal: | |||
|---|---|---|---|
| Class ofquotedfinancialproducts: | Ordinaryshares | ||
| Mark Brendon Waller & Angela | |||
| Nature of relevantinterest: | Laura Waller | ||
| _For that relevant interest,- _ | |||
| Number heldinclass: | 506,692 ordinaryshares | ||
| Mark Brendon Waller & Angela | |||
| Currentregisteredholder(s): | Laura Waller | ||
| For a derivative relevant interest,- | |||
| Type ofderivative: | |||
| Details of derivative,- | |||
| The notional value of the derivative (if any) or the notional amount of underlying financial | |||
| products (if any): | |||
| A statement as to whether the derivative is cash settled or physically settled: | |||
| Maturity date of the derivative (if any): | |||
| Expiry date of the derivative (if any): | |||
| The price's specified terms (if any): | |||
| Any other details needed to understand how the amount of the consideration payable | |||
| under the derivative or the value of the derivative is affected by the value of the | |||
| underlyingfinancialproducts: | |||
| For that derivative relevant interest,- | |||
| Parties to the derivative: | |||
| If the director or senior manager is not a party to the derivative, the nature of the relevant | |||
| interest in the derivative: |
| Certification | ||
|---|---|---|
| I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. |
||
| Signature of director or officer: | ||
| Date of signature: | ||
| or | ||
| Signature of person authorised to sign on behalf of director or officer: | ||
| Date of signature: | 2-Dec-19 | |
| Name and title of authorised person: | Janelle Cain, General Counsel, EBOS Group Limited |
|